We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent
News

Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent

Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent
News

Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Stem Cell Innovations Announces Issuance of Fundamental Human Stem Cell Patent"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Stem Cell Innovations, Inc. has announced the issuance of key patent covering human pluripotent stem cells in the United States.

“The patent provides a broad blocking position for the pluripotent cells of interest to Stem Cell Innovations as it covers isolated human primordial germ cell derived pluripotent cells,” said Stem Cell Innovations CEO Dr. James Kelly.

“We believe that this is a fundamental patent in human stem cell biology and an important addition to our foundational IP.” The patent was issued in the United States as U.S. Patent No. 7,153,684 and is licensed exclusively to Stem Cell Innovations.

Stem Cell Innovations is developing PluriCells™, a new human stem cell technology derived from primordial germ cells of fetal tissue. PluriCells are distinct from ES cells and are believed to be outside the competitive patents on human ES cells.

Advertisement